Oppenheimer & Co. Inc. Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oppenheimer & Co. Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,785 shares of the medical equipment provider's stock after selling 560 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Intuitive Surgical were worth $9,283,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. State Street Corp boosted its stake in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC lifted its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Geode Capital Management LLC boosted its position in Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC increased its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after acquiring an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. raised its position in shares of Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $9.38 during trading on Friday, reaching $573.15. The company had a trading volume of 2,399,758 shares, compared to its average volume of 1,733,598. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm's 50-day simple moving average is $569.87 and its 200 day simple moving average is $528.64. The firm has a market capitalization of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Piper Sandler reiterated an "overweight" rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective on the stock. Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $613.10.

Insider Buying and Selling

In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 270 shares of the business's stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,077 shares of company stock worth $4,620,025. 0.80% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.